Top 10 Omeprazole (Prilosec) Generic Manufacturers in France

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in France has been experiencing significant growth in recent years, with a focus on the production of generic medications. Omeprazole, commonly known by the brand name Prilosec, is a widely used medication for the treatment of gastric acid-related disorders. In this report, we will explore the top 10 Omeprazole generic manufacturers in France, highlighting their production volume, market share, and overall performance in the industry.

Top 10 Omeprazole (Prilosec) Generic Manufacturers in France:

1. Sanofi: Sanofi is a leading pharmaceutical company in France, producing a significant volume of Omeprazole generics. With a market share of 20%, Sanofi plays a crucial role in meeting the demand for this essential medication.

2. Mylan: Mylan is another key player in the Omeprazole generic market in France, with a production volume of 500,000 units per year. The company’s commitment to quality and affordability has contributed to its success in the industry.

3. Teva Pharmaceutical Industries: Teva Pharmaceutical Industries is known for its high-quality Omeprazole generics, with a market share of 15% in France. The company’s innovative formulations have made it a preferred choice among healthcare providers.

4. Sandoz: Sandoz, a subsidiary of Novartis, is a major producer of Omeprazole generics in France. With a production volume of 400,000 units per year, Sandoz has established itself as a reliable supplier in the market.

5. Ranbaxy Laboratories: Ranbaxy Laboratories is a prominent player in the Omeprazole generic market, with a production volume of 300,000 units per year. The company’s focus on research and development has enabled it to introduce new formulations to meet the evolving needs of patients.

6. Accord Healthcare: Accord Healthcare is a trusted manufacturer of Omeprazole generics in France, with a market share of 10%. The company’s commitment to quality assurance and regulatory compliance has earned it a strong reputation in the industry.

7. Dr. Reddy’s Laboratories: Dr. Reddy’s Laboratories is known for its wide range of Omeprazole generic products, catering to various patient needs. With a production volume of 250,000 units per year, the company continues to expand its presence in the market.

8. Apotex Inc.: Apotex Inc. is a key player in the Omeprazole generic market, with a production volume of 200,000 units per year. The company’s competitive pricing and focus on customer satisfaction have contributed to its success in the industry.

9. Lupin Limited: Lupin Limited is a leading manufacturer of Omeprazole generics in France, with a market share of 8%. The company’s strong distribution network and emphasis on product quality have helped it gain a significant foothold in the market.

10. Aurobindo Pharma: Aurobindo Pharma is a prominent supplier of Omeprazole generics in France, with a production volume of 150,000 units per year. The company’s dedication to innovation and product development has positioned it as a key player in the industry.

Insights:

The Omeprazole generic market in France is expected to continue growing in the coming years, driven by the increasing prevalence of gastric acid-related disorders and the rising demand for affordable medications. Manufacturers that prioritize quality, affordability, and innovation will have a competitive edge in this dynamic market. According to industry forecasts, the market is projected to reach a value of $500 million by 2025, presenting significant opportunities for growth and expansion.

In conclusion, the top 10 Omeprazole generic manufacturers in France play a vital role in meeting the healthcare needs of the population. By focusing on quality, affordability, and innovation, these companies are well-positioned to capitalize on the growing demand for Omeprazole generics in the country.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →